GenFleet Therapeutics (Shanghai) Inc. (HKG:2595)

HKG:2595 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Jul 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Market Capitalization	10,037	8,807	-	-
Market Cap Growth	-	-	-	-
Enterprise Value	7,841	8,510	-	-
Last Close Price	27.10	23.78	-	-
PS Ratio	69.24	60.76	-	-
PB Ratio	4.97	4.36	-	-
P/TBV Ratio	4.97	4.36	-	-
EV/Sales Ratio	54.09	58.71	-	-
Debt / Equity Ratio	0.06	0.06	-0.04	-0.02
Net Debt / Equity Ratio	-1.09	-1.09	0.17	0.23
Net Debt / EBITDA Ratio	7.19	7.19	1.10	1.10
Net Debt / FCF Ratio	14.53	14.53	1.58	1.48
Asset Turnover	0.09	0.09	0.18	-
Inventory Turnover	4.07	4.07	5.26	-
Quick Ratio	5.75	5.75	0.21	0.23
Current Ratio	5.85	5.85	0.23	0.25
Return on Assets (ROA)	-12.49%	-12.49%	-33.42%	-
Return on Capital Employed (ROCE)	-15.30%	-15.30%	16.20%	22.10%
Earnings Yield	-19.90%	-22.67%	-	-
FCF Yield	-1.51%	-1.72%	-	-
Buyback Yield / Dilution	-14.39%	-14.39%	-17.40%	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 1, 2026

Data Sources Report a data error